Product Description
| Cat Number | VK515016 |
|---|---|
| Category | Biosimilar |
| Pack Size | 100 ug |
| Description | Diridavumab,thealternativenamesCR6261,isahumanmonoclonalantibodydirectagainstinfluenzaAhemagglutinin.TheCR6261antibodywasfirstdiscoveredbytheScrippsInstituteandCrucell,adutchbiopharmaceuticalcompany,andlaterdevelopedbyJanssenPharmaceuticalCompaniesofJohnson&Johnsonunderthetradenamediridavumab. Cr6261isunderinvestigationinclinicaltrialNCT02016066(AStudytoAssesstheSafety,PharmacokineticsandImmunogenicityofDiridavumabinJapaneseHealthyParticipants). |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | HA/Hemagglutinin |
| Clonality | Monoclonal |
| Synonyms | CR-6261,CR6261,CAS:1393659-46-5 |
| Host | Human |
| Concentration | 1.41mg/ml |
| Isotype | IgG1,lambda |
| Form | Liquid |
| Purity | >95% as determined by SDS-PAGE. |
| Specie Reactivity | InfluenzaAvirus |
| Storage | 0.01M PBS, pH7.4. |
| Note | The product is for research use only |
Share Item: